Clover Corporation’s (ASX:CLV) N3RO trial shows improvement in IQ of premature infants
Clover Corporation (CLV) announces the release of new results from its clinical…
Clover Corporation Limited (ASX:CLV)
About Clover Corporation Limited
Key Information
CLV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 21/07/2022 | Change in substantial holding from PPT | 142.55KB | 205 |
| 28/04/2022 | Payment of FY22 Interim Dividend | 245.23KB | 349 |
| 21/03/2022 | Price Sensitive PS Clinical research shows improvement inIQ of premature infant | 115KB | 1.2K |
| 16/03/2022 | Dividend/Distribution - CLV | 22.52KB | 1.4K |
| 16/03/2022 | Price Sensitive PS Clover 1H FY22 Investor Presentation | 706.55KB | 388 |
| 16/03/2022 | Price Sensitive PS Clover FY22 Half Year Results Announcement | 122.27KB | 282 |
| 16/03/2022 | Price Sensitive PS Clover FY22 Half Year Report and Accounts | 313.9KB | 321 |
| 03/03/2022 | Price Sensitive PS Settlement of Intellectual Property Dispute | 105.64KB | 364 |